These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

535 related items for PubMed ID: 12120256

  • 1. Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug.
    Capdeville R, Buchdunger E, Zimmermann J, Matter A.
    Nat Rev Drug Discov; 2002 Jul; 1(7):493-502. PubMed ID: 12120256
    [Abstract] [Full Text] [Related]

  • 2. Imatinib: a targeted clinical drug development.
    Capdeville R, Silberman S.
    Semin Hematol; 2003 Apr; 40(2 Suppl 2):15-20. PubMed ID: 12783370
    [Abstract] [Full Text] [Related]

  • 3. [Imatinib].
    Urabe A.
    Gan To Kagaku Ryoho; 2003 Aug; 30(8):1191-6. PubMed ID: 12938280
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Imatinib as a paradigm of targeted therapies.
    Druker BJ.
    Adv Cancer Res; 2004 Aug; 91():1-30. PubMed ID: 15327887
    [Abstract] [Full Text] [Related]

  • 7. [New oncological treatment principle with imatinib].
    Kuenen BC, Pinedo HM.
    Ned Tijdschr Geneeskd; 2003 Oct 18; 147(42):2044-5. PubMed ID: 14606348
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Tyrosine kinase inhibitor STI571: new possibility in the treatment of chronic myeloid leukemia].
    Molnár L, Losonczy H.
    Orv Hetil; 2002 Oct 20; 143(42):2379-84. PubMed ID: 12440260
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Inhibition of the Bcr-Abl tyrosine kinase as a therapeutic strategy for CML.
    Druker BJ.
    Oncogene; 2002 Dec 09; 21(56):8541-6. PubMed ID: 12476300
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [STI571: a summary of targeted therapy].
    Czyz M, Jakubowska J.
    Postepy Hig Med Dosw (Online); 2006 Dec 09; 60():677-96. PubMed ID: 17245318
    [Abstract] [Full Text] [Related]

  • 16. The c-kit tyrosine kinase inhibitor STI571 for colorectal cancer therapy.
    Attoub S, Rivat C, Rodrigues S, Van Bocxlaer S, Bedin M, Bruyneel E, Louvet C, Kornprobst M, André T, Mareel M, Mester J, Gespach C.
    Cancer Res; 2002 Sep 01; 62(17):4879-83. PubMed ID: 12208734
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Platelet-derived growth factor receptors: a therapeutic target in solid tumors.
    George D.
    Semin Oncol; 2001 Oct 01; 28(5 Suppl 17):27-33. PubMed ID: 11740804
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.